Loading clinical trials...

WITHDRAWNPhase 2/3NCT04152655

A Study of Efficacy and Safety of Idebenone Vs. Placebo in Prodromal Parkinson Disease

To investigate whether 24 months of idebenone may reduce the progression from Prodromal Parkinson disease (PPD) to Parkinson disease (PD).

Lead sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

NCT06553625 · Parkinson Disease, Dystonia, and more

RECRUITINGNA

Safety and Tolerability of Patterned Stimulation for DBS in the Home Setting

NCT07410598 · Parkinson Disease, Deep Brain Stimulation

RECRUITINGNA

Neuroplasticity in RBD

NCT05471960 · REM Sleep Behavior Disorder

RECRUITING

Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD

NCT07187843 · Parkinson Disease, Parkinsonian Disorders, and more

RECRUITINGPhase 1

A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease

NCT07543861 · Parkinson Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 7, 2025Terms

Trial snapshot

StatusWITHDRAWN

PhasePHASE2/PHASE3

Enrollment—

Start dateJan 2020

Last updatedJan 7, 2025

Condition

REM Sleep Behavior Disorder Parkinson Disease

Locations shown

Second Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, Zhejiang

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 7, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions